Article
Genome-wide association study identifies kallikrein 5 in type 2 inflammation-low asthma
26 Apr 2022
Abstract excerpt
BACKGROUND: Clinical studies of type 2 (T2) cytokine-related neutralizing antibodies in asthma have identified a substantial subset of patients with low levels of T2 inflammation who do not benefit from T2 cytokine neutralizing antibody treatment. Non-T2 mechanisms are poorly understood in asthma but represent a redefined unmet medical need. OBJECTIVE: We sought to gain a better understanding of genetic...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
